Skip to main content
Integrity IndexIntegrity Index
← Companies
RGEN

REPLIGEN CORP

Data as of Sep 17, 2026
RGEN
CIK 730272HEALTHCAREBiological Products, (No Diagnostic Substances)
Federal contracts since 2024
$378K
3 awards · latest Sep 3, 2026

Trades

8 reported trades in RGEN by 3 members of Congress since Jan 20, 2022: 3 purchases and 5 sales. Amounts are the ranges members report on periodic transaction reports.

Trades
8
Buys / sells
3 / 5
Members
3

Most recent

  • RLisa McclainSale$1,001+Oct 31, 2025
  • RLisa McclainPurchase$1,001+Oct 30, 2025
  • RLisa McclainSale$1,001+Oct 30, 2025
  • RLisa McclainPurchase$1,001+Jul 22, 2025
  • RLisa McclainSale$1,001+Jun 17, 2025
  • RLisa McclainPurchase$1,001+Jun 11, 2025
  • RJefferson ShreveSale$15,001+Apr 7, 2025
  • DRo KhannaSale$1,001+Jan 20, 2022

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to REPLIGEN CORP through its SEC registration (CIK 730272) and tickers RGEN.

As of: contract actions through Sep 3, 2026. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.